Rss Feed

A new study led by the Harvard Pilgrim Health Care Institute finds that mental health care gaps for U.S. children remain stark: one in five households reported a child needing treatment, yet nearly a quarter didn't receive it, and many who did still struggled to access care.

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

People with inflammatory bowel disease (IBD) and precancerous colorectal lesions are much more likely to develop colorectal cancer, a new study shows.

Certain gut bacteria in infants may reduce the risk of developing allergies later in childhood. This is the finding of new research from the ALADDIN study at Karolinska Institutet, published in Nature Microbiology.

Researchers from the NeuroAD group (Neuropathology of Alzheimer's Disease) within the Department of Cell Biology, Genetics and Physiology at the University of Málaga, also affiliated with IBIMA-BIONAND Platform and CIBERNED, have made a pioneering breakthrough in the fight against this disease by identifying astrocytes as a promising cellular target for the development of future therapies.

Announcing a new article publication for BIO Integration journal. In recent years, phytochemicals and medicinal plants have increasingly been used to treat autoimmune diseases, such as rheumatoid arthritis (RA).

Healthcare systems worldwide are increasingly recognizing the importance of environmental sustainability, yet little is known about how healthcare professionals perceive and implement sustainable practices in Kazakhstan.

How you take probiotics can affect their impact on the brain. A study from örebro University points to new possibilities for personalized approaches, depending on whether the primary aim is, for example, to improve memory or reduce depression.

A recent study, published in Nature Communications, shows that in the Netherlands, people who are diagnosed with HIV are less likely to be employed, work fewer hours, earn less income, and are more likely to receive disability benefits up to seven years after diagnosis.

A team led by LMU physician Sebastian Kobold has found a way to allow the body's immune system to destroy solid tumors.

Insulin resistance - when the body doesn't properly respond to insulin, a hormone that helps control blood glucose levels - is one of the fundamental causes of diabetes.

HER2-positive gastric cancer accounts for a substantial proportion of advanced cases and has long been treated with HER2-targeted therapies.

Spinal cord injury remains one of the most challenging neurological conditions to treat, largely because damage continues to worsen long after the initial trauma.

Physical therapy is a key step on the path to recovery after injuries or certain surgical procedures. A new survey by The Ohio State University Wexner Medical Center shows 3 out of 4 (76%) patients don't complete their physical therapy homework, leading to stalled recoveries and potential surgical setbacks.

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are being utilized in CastleVax’s Phase II clinical trial for CVAX-01, an intranasal COVID-19 vaccine candidate.

Secondary infections caused by bacteria or viruses during hospital care remain a long-standing global challenge, despite advances in modern medicine.

More than half of college students are lonely – and those who use social media the most are particularly likely to feel isolated, a study of tens of thousands of 18 to 24-year-olds in the US shows.

Gastric cancer remains the fifth leading cause of cancer-related deaths worldwide. Although its overall incidence has declined, early-onset cases—diagnosed before age 50—display unique biological and clinical patterns.

Long-term air pollution exposure is associated with faster progression of disability in older adults, highlighting critical public health implications.

An international study led by researchers from the Sant Pau Research Institute (IR Sant Pau) shows that advanced use of magnetic resonance imaging (MRI) allows much more accurate identification of patients with progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD).